Sorafenib in Elderly mRCC
NCT01728948
·
clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Renal Cell
Interventions
DRUG:
Sorafenib (Nexavar, BAY43-9006)
Sponsor
Bayer